Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience

Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience

BackgroundInfiltrative hepatocellular carcinoma (HCC) remains a therapeutic challenge due to its aggressive course and poor prognosis. Hepatic arterial infusion chemotherapy (HAIC) plus immune checkpoint inhibitors (ICIs) and molecular targeted therapies (MTTs) has shown early promise for advanced H...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zizhuo Wang, Songlin Song, Lijie Zhang, Tingting Yang, Wei Yao, Bin Liang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	infiltrative hepatocellular carcinoma hepatocellular carcinoma hepatic arterial infusion immunotherapy molecular targeted therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1474442/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Feasibility, efficacy, and safety of ventral caudal artery access for transarterial chemoembolization in a rat hepatocellular carcinoma model
by: Wei Hong, et al.
Published: (2025-07-01)

Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements
by: Wei Xu, et al.
Published: (2025-05-01)

Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update
by: Shiguang Chen, et al.
Published: (2025-12-01)

Identification of CCDC58 as a potential predictive biomarker of immune cell infiltration in hepatocellular carcinoma
by: Zishen Liu, et al.
Published: (2025-04-01)

The antineoplastic effects of nuciferine on hepatocellular carcinoma are associated with suppression of the HER2-AKT/ERK1/2 signaling pathway
by: Tiantian Li, et al.
Published: (2025-05-01)

Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma: A Three-Dimensional Visualization Perspective
by: Tan Y, et al.
Published: (2025-04-01)

Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy
by: Zheng X, et al.
Published: (2025-06-01)

Risk Factors and Predictive Analysis of Acute Severe Abdominal Pain After Hepatic Artery Infusion Chemotherapy in Patients with Hepatocellular Carcinoma
by: Li J, et al.
Published: (2025-02-01)

Successful treatment of tumor lysis syndrome associated with hepatic artery infusion chemotherapy in a patient with hepatocellular carcinoma: a case report
by: Miao Li, et al.
Published: (2024-12-01)

Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma
by: Tianchen Zhang, et al.
Published: (2023-02-01)

Hepatic arterial infusion chemotherapy and sequential ablation treatment in large hepatocellular carcinoma
by: Huimin You, et al.
Published: (2022-12-01)

Impact of intraperitoneal lavage with lobaplatin on survival in patients undergoing hepatectomy for ruptured hepatocellular carcinoma
by: Xing Lv, et al.
Published: (2025-03-01)

Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial
by: Kugeluke Yalikun, et al.
Published: (2025-05-01)

Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
by: Ji Yeon Lee, et al.
Published: (2024-12-01)

Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Research in context
by: Wei Gao, et al.
Published: (2025-05-01)

Expression and clinical significance of ACAA1 in hepatocellular carcinoma
by: LIANG Ziyuan, et al.
Published: (2025-04-01)

Anxiety is a risk prognosis factor for hepatocellular carcinoma with portal vein tumor thrombus who underwent hepatic arterial infusion chemotherapy: a propensity score-matching cohort study
by: Hao-yang Tan, et al.
Published: (2025-05-01)

Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies
by: Hao-Huan Tang, et al.
Published: (2025-04-01)

Establishment of prognostic risk model related to disulfidptosis and immune infiltration in hepatocellular carcinoma
by: Zhe Xu, et al.
Published: (2024-12-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01)

Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma
by: Chen PY, et al.
Published: (2025-06-01)

TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma
by: Lingyun Kuang, et al.
Published: (2024-12-01)

Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma
by: Chang-Qing Yin, et al.
Published: (2024-12-01)

Conversion study of hepatocellular carcinoma using HAIC combined with lenvatinib and PD-1/L1 immunotherapy under the guidance of BCLC staging
by: Weihao Zhang, et al.
Published: (2025-06-01)

Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review
by: Ying Wu, et al.
Published: (2025-03-01)

Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
by: Li X, et al.
Published: (2025-01-01)

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma
by: Liang Yang, et al.
Published: (2025-03-01)

Radiotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion chemotherapy of RALOX versus FOLFOX for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score-matching cohort study
by: Hao-yang Tan, et al.
Published: (2025-05-01)

Discovery of novel diagnostic biomarkers of hepatocellular carcinoma associated with immune infiltration
by: Qiang Liu, et al.
Published: (2025-12-01)

Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-001): a phase II trial
by: Lujun Shen, et al.
Published: (2025-05-01)

Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
by: Yu-zhe Cao, et al.
Published: (2024-11-01)

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma
by: Shaohua Li, et al.
Published: (2024-10-01)

Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
by: Zhong S, et al.
Published: (2025-03-01)

FLT3 is associated with dendritic cell infiltration, tertiary lymphoid structure construction, and predict response to checkpoint inhibitors immunotherapy in solid cancers
by: Yongchang Tang, et al.
Published: (2025-01-01)

Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma
by: Xia Y, et al.
Published: (2025-07-01)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
by: Kai‐Rong Lin, et al.
Published: (2018-08-01)

Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma
by: Xuezhong Zhang, et al.
Published: (2025-05-01)

Prognostic relevance of sarcopenia and tumor‐infiltrating CD8+ T cells in patients with hepatocellular carcinoma
by: Shunsuke Doi, et al.
Published: (2025-03-01)

Single‐Nucleus and Spatial Transcriptome Profiling Delineates the Multicellular Ecosystem in Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
by: YeXing Huang, et al.
Published: (2025-02-01)

Survival outcomes after surgical resection of huge HCC (≥ 10 cm) with or without neoadjuvant hepatic arterial infusion chemotherapy
by: Chia-Ling Chiang, et al.
Published: (2025-06-01)